9-ING-41 in Patients With Advanced Cancers
Actuate Therapeutics Inc.
Actuate Therapeutics Inc.
Incyte Corporation
Eli Lilly and Company
University of Maryland, Baltimore
Masonic Cancer Center, University of Minnesota
Northwestern University
Altor BioScience
Dartmouth-Hitchcock Medical Center